scholarly article | Q13442814 |
P50 | author | Charles A. Dinarello | Q834442 |
P2093 | author name string | Kim S | |
Lee SJ | |||
Choe YK | |||
Hoshino T | |||
Lee KA | |||
Park SN | |||
Cho YS | |||
Yoon DY | |||
Shim JH | |||
Cho MC | |||
Ko KK | |||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | human papillomavirus 16 | Q69461345 |
P304 | page(s) | 497-504 | |
P577 | publication date | 2001-07-01 | |
P1433 | published in | Journal of Immunology | Q3521441 |
P1476 | title | Both E6 and E7 oncoproteins of human papillomavirus 16 inhibit IL-18-induced IFN-gamma production in human peripheral blood mononuclear and NK cells | |
P478 | volume | 167 |
Q39949375 | Activating NK cell receptor ligands are differentially expressed during progression to cervical cancer. |
Q39611935 | Activation of the interleukin-32 pro-inflammatory pathway in response to human papillomavirus infection and over-expression of interleukin-32 controls the expression of the human papillomavirus oncogene |
Q34298390 | Activation of the retinoblastoma tumor suppressor mediates cell cycle inhibition and cell death in specific cervical cancer cell lines |
Q55507801 | Activities of stromal and immune cells in HPV-related cancers. |
Q38134426 | Anal intraepithelial neoplasia and squamous cell carcinoma in HIV-infected adults |
Q35687684 | Anti-cytokine Ab immune therapy: present status and perspectives |
Q38216925 | Are human polyomaviruses co-factors for cancers induced by other oncoviruses? |
Q36099498 | Biology of human papillomavirus infection and immune therapy for HPV-related head and neck cancers |
Q36603969 | Clinical and experimental approaches to the pathophysiology of interleukin-18 in cancer progression |
Q24336015 | Cloning and characterization of an isoform of interleukin-21 |
Q47736286 | CpG-ODN-stimulated dendritic cells act as a potent adjuvant for E7 protein delivery to induce antigen-specific antitumour immunity in a HPV 16 E7-associated animal tumour model |
Q33740390 | Dense genotyping of immune-related loci identifies variants associated with clearance of HPV among HIV-positive women in the HIV epidemiology research study (HERS). |
Q54700308 | E5 protein of human papillomavirus type 16 selectively downregulates surface HLA class I. |
Q34895151 | Evasion of host immunity directed by papillomavirus-encoded proteins |
Q33934824 | Genetic dysregulation in recurrent respiratory papillomatosis |
Q64998345 | HPV-16 Infection Is Associated with a High Content of CD39 and CD73 Ectonucleotidases in Cervical Samples from Patients with CIN-1. |
Q38859115 | Human papillomavirus E7 oncoprotein increases production of the anti-inflammatory interleukin-18 binding protein in keratinocytes. |
Q37776459 | Human papillomavirus and oropharynx cancer: Biology, detection and clinical implications |
Q45434536 | Human papillomavirus hpv-16 DNA as an epitheliotropic virus that induces hyperproliferation in squamous penile tissue |
Q36086249 | Human papillomavirus immunization is associated with increased expression of different innate immune regulatory receptors |
Q34743451 | Human papillomavirus: a review |
Q36550902 | Human papillomaviruses and cervical cancer |
Q46913482 | IL-18 is a key proximal mediator of contact hypersensitivity and allergen-induced Langerhans cell migration in murine epidermis |
Q34325776 | IL-27 Regulates IL-18 binding protein in skin resident cells |
Q37636476 | IPA Analysis of Cervicovaginal Fluid from Precancerous Women Points to the Presence of Biomarkers for the Precancerous State of Cervical Carcinoma |
Q54785057 | Identification and characterisation of a group of cervical carcinoma patients with profound downregulation of intratumoral Type 1 (IFNgamma) and Type 2 (IL-4) cytokine mRNA expression. |
Q40467969 | Imiquimod is a strong inhibitor of tumor cell-induced angiogenesis. |
Q34570129 | Immune evasion in human papillomavirus-associated cervical cancer |
Q34657561 | Immune therapy for human papillomaviruses-related cancers |
Q46490967 | Immunosuppressive activity of proteases in cervical carcinoma |
Q37318349 | Interaction of human papillomaviruses with the host immune system: a well evolved relationship. |
Q33468660 | Low NKp30, NKp46 and NKG2D expression and reduced cytotoxic activity on NK cells in cervical cancer and precursor lesions. |
Q34337237 | NK cells and virus-related cancers |
Q49724715 | Natural Killer Cell-Based Immunotherapy in Gynecologic Malignancy: A Review. |
Q35642759 | Papillomavirus E5: the smallest oncoprotein with many functions |
Q81101652 | Polymorphisms of interleukin (IL)-1alpha, IL-1beta, IL-6, IL-10, and IL-18 and the risk of ovarian cancer |
Q33220172 | Protein profiling and identification of modulators regulated by human papillomavirus 16 E7 oncogene in HaCaT keratinocytes by proteomics. |
Q90284810 | Reduced Expression of IL-1β and IL-18 Proinflammatory Interleukins Increases the Risk of Developing Cervical Cancer |
Q37825525 | Regulation of immune responses to HPV infection and during HPV-directed immunotherapy |
Q42244628 | Relationship between the interleukin-6-174 gene and mannose-binding lectin codon 54 gene polymorphisms and condyloma acuminatum. |
Q33933870 | Sensitization of cervix cancer cells to Adriamycin by Pentoxifylline induces an increase in apoptosis and decrease senescence |
Q35092966 | Soluble interleukin-18 receptor complex is a novel biomarker in rheumatoid arthritis |
Q57218500 | The E5 protein of human papillomavirus type 16 perturbs MHC class II antigen maturation in human foreskin keratinocytes treated with interferon-gamma |
Q90270888 | The Interplay between Antiviral Signalling and Carcinogenesis in Human Papillomavirus Infections |
Q37418916 | Therapeutic vaccines against human papillomavirus and cervical cancer |
Q36464830 | Vaccinia virus interleukin-18-binding protein promotes virulence by reducing gamma interferon production and natural killer and T-cell activity |
Q34983819 | Viral evasion of natural killer cells |
Q36455030 | Warts and all: human papillomavirus in primary immunodeficiencies |
Search more.